Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessmentFRONTIERS IN TOXICOLOGYIF4.62024-04-053OAAI
Principles and procedures for assessment of acute toxicity incorporating in silico methodsCOMPUTATIONAL TOXICOLOGYIF2.92022-11-018OAAI
In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicitiesCOMPUTATIONAL TOXICOLOGYIF2.92021-11-0113OAAI
In silico approaches in organ toxicity hazard assessment: Current status and future needs in predicting liver toxicityCOMPUTATIONAL TOXICOLOGYIF2.92021-11-0122OAAI
Skin sensitization in silico protocolsilico协议中的皮肤致敏REGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52020-10-0131OAAI
Genetic toxicology in silico protocol计算机协议中的遗传毒理学REGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52019-10-0149OAAI
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52019-03-0122OAAI
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52016-06-0138PREAI
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52016-06-0182OAAI
Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasisTOXICOLOGICAL SCIENCESIF4.12007-11-2019PREAI